N-NAIL Score Demonstrates Greater Accuracy than NAPSI in Diagnosing Nail Psoriasis
A recent study reveals that the N-NAIL score outperforms NAPSI in accurately diagnosing nail psoriasis, offering a simpler and more reliable tool for clinicians and researchers.
Recent research published in the International Journal of Dermatology highlights the superior diagnostic performance of the Nijmegen-Nail Psoriasis Activity Index Tool (N-NAIL) compared to the Nail Psoriasis Severity Index (NAPSI) for identifying nail psoriasis. Both scoring systems are used to evaluate the severity of nail involvement in psoriasis patients, but findings show that N-NAIL offers improved accuracy and simplicity.
The study, led by Dr. Evi C.C. Rikken from Radboud University Medical Center in Nijmegen, involved a cohort of 104 patients with psoriasis, of whom 68 had confirmed nail psoriasis. Researchers established optimal cutoff points for each scoring tool to determine their diagnostic efficacy. The N-NAIL, with a cutoff value of 2, achieved a sensitivity of 83.8% and specificity of 83.3% in diagnosing nail psoriasis among the psoriasis population. Similarly, in the general population, this cutoff maintained high sensitivity (83.8%) but a slightly lower specificity (67.3%).
In comparison, the NAPSI showed its best performance at a cutoff of 7 for patients with psoriasis, with a sensitivity of 80.9% and specificity of 69.4%. In the broader population, a cutoff of 10 was optimal, yielding a sensitivity of 72.1% and specificity of 70.2%.
The authors emphasized that the N-NAIL’s streamlined single-version scoring system makes it easier and quicker for dermatologists and researchers to apply, reducing confusion and facilitating more efficient diagnosis. The study underlines that the N-NAIL's higher accuracy and ease of use make it a preferable choice over NAPSI for clinical and research purposes.
For more details, refer to the original study: Evi C. C. Rikken et al., "What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?", International Journal of Dermatology (2025). [DOI: 10.1111/ijd.70024]
Source: https://medicalxpress.com/news/2025-08-score-accurate-napsi-psoriasis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Combination of Osimertinib and Chemotherapy Enhances Progression-Free Survival in EGFR-Mutated Non-Small Cell Lung Cancer
Combining osimertinib with chemotherapy significantly extends progression-free and overall survival in patients with EGFR-mutated non-small cell lung cancer, according to recent clinical trial results.
Majority of NHS Staff Cite Improved Pay as Crucial for Retention
A new survey reveals that nearly two-thirds of NHS staff believe improved pay is essential to improve retention and address workforce shortages, amid ongoing pay disputes.
Innovative DNA Approach May Overcome Immunotherapy Resistance in Colorectal Cancer
A breakthrough from the University of Alberta reveals a DNA-based strategy to activate immune responses in colorectal cancers resistant to current immunotherapies, potentially leading to more effective treatments.
U.S. Alcohol-Related Deaths Nearly Double from 1999 to 2024, Study Finds
Alcohol-induced deaths in the U.S. have nearly doubled from 1999 to 2024, with significant increases during the COVID-19 pandemic, especially among young women and Native American populations.